| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |